BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

807 related articles for article (PubMed ID: 19571648)

  • 1. Herpes Zoster and Postherpetic Neuralgia: a review of the effects of vaccination.
    Johnson RW
    Aging Clin Exp Res; 2009 Jun; 21(3):236-43. PubMed ID: 19571648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes zoster and postherpetic neuralgia.
    Johnson RW
    Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):21-6. PubMed ID: 20192714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination: a new option to reduce the burden of herpes zoster.
    Mick G
    Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of herpes zoster (shingles) and postherpetic neuralgia.
    Johnson RW; Whitton TL
    Expert Opin Pharmacother; 2004 Mar; 5(3):551-9. PubMed ID: 15013924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine.
    Tseng HF; Lewin B; Hales CM; Sy LS; Harpaz R; Bialek S; Luo Y; Jacobsen SJ; Reddy K; Huang PY; Zhang J; Anand S; Bauer EM; Chang J; Tartof SY
    J Infect Dis; 2015 Oct; 212(8):1222-31. PubMed ID: 26038400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes zoster (shingles) and postherpetic neuralgia.
    Sampathkumar P; Drage LA; Martin DP
    Mayo Clin Proc; 2009 Mar; 84(3):274-80. PubMed ID: 19252116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
    Pellissier JM; Brisson M; Levin MJ
    Vaccine; 2007 Nov; 25(49):8326-37. PubMed ID: 17980938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of herpes zoster and postherpetic neuralgia].
    Hüning S; von Dücker L; Kohl WK; Nashan D
    Hautarzt; 2019 Aug; 70(8):645-656. PubMed ID: 31270550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia.
    Brisson M; Pellissier JM; Camden S; Quach C; De Wals P
    Hum Vaccin; 2008; 4(3):238-45. PubMed ID: 18382137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life.
    Johnson RW; Bouhassira D; Kassianos G; Leplège A; Schmader KE; Weinke T
    BMC Med; 2010 Jun; 8():37. PubMed ID: 20565946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutritional factors in herpes zoster, postherpetic neuralgia, and zoster vaccination.
    Chen JY; Chang CY; Lin YS; Hu ML
    Popul Health Manag; 2012 Dec; 15(6):391-7. PubMed ID: 23088666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination against herpes zoster in developed countries: state of the evidence.
    Drolet M; Oxman MN; Levin MJ; Schmader KE; Johnson RW; Patrick D; Mansi JA; Brisson M
    Hum Vaccin Immunother; 2013 May; 9(5):1177-84. PubMed ID: 23324598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of varicella zoster virus: chronic pain.
    Opstelten W; McElhaney J; Weinberger B; Oaklander AL; Johnson RW
    J Clin Virol; 2010 May; 48 Suppl 1():S8-13. PubMed ID: 20510265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient.
    Johnson RW; Wasner G; Saddier P; Baron R
    Drugs Aging; 2008; 25(12):991-1006. PubMed ID: 19021299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes zoster vaccine: A health economic evaluation for Switzerland.
    Blank PR; Ademi Z; Lu X; Szucs TD; Schwenkglenks M
    Hum Vaccin Immunother; 2017 Jul; 13(7):1495-1504. PubMed ID: 28481678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective cohort study evaluating the incidence of herpes zoster and postherpetic neuralgia after a live attenuated Oka-strain herpes zoster vaccine in a real-world setting in Japan.
    Yaegashi M; Matsui H; Yoshida A; Ban H; Miyazaki R; Oda N; Hattori K; Motomura Y; Usami H; Matsushita H
    Vaccine; 2024 Jan; 42(3):464-470. PubMed ID: 38172019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Herpes Zoster and its prevention in Italy. Scientific consensus statement].
    Franco E; Gabutti G; Bonanni P; Conversano M; Stefano Valente ME; Ferro A; Icardi G; Antonio Volpi ML; Maggi S; Rossi A; Scotti S; Vitale F; Greco D;
    Ig Sanita Pubbl; 2014; 70(1):111-27. PubMed ID: 24770367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Herpes zoster and postherpetic neuralgia - prevention by vaccination?].
    Wutzler P
    Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S90-4. PubMed ID: 19353479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany.
    Ultsch B; Weidemann F; Reinhold T; Siedler A; Krause G; Wichmann O
    BMC Health Serv Res; 2013 Sep; 13():359. PubMed ID: 24070414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination against Herpes Zoster and Postherpetic Neuralgia.
    Oxman MN; Levin MJ;
    J Infect Dis; 2008 Mar; 197 Suppl 2(Suppl 2):S228-36. PubMed ID: 18419402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.